Why do medications with little or no efficacy continue to be prescribed in the management of patients with bipolar disorder?
暂无分享,去创建一个
M. Berk | R. Milev | E. Brietzke | L. Yatham | F. Gomes
[1] A. Nierenberg,et al. 20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings. , 2020, The American journal of psychiatry.
[2] T. Brennan,et al. Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing , 2017, JAMA.
[3] A. Nierenberg,et al. Customization in prescribing for bipolar disorder. , 2012, Health economics.
[4] J. Ioannidis,et al. Persistence of contradicted claims in the literature. , 2007, JAMA.
[5] M. Chren,et al. Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents , 2006, Annals of Internal Medicine.